Single-Port-Plus-One Thoracoscopic Lobectomy for Infants with Congenital Pulmonary Airway Malformation: Initial Experience

<b><i>Objective:</i></b> To investigate the safety and feasibility of single-port-plus-one (SP + 1) thoracoscopic lobectomy in the treatment of congenital pulmonary airway malformation (CPAM) in infants. <b><i>Methods:</i></b> The clinical data of 35 infants who underwent SP + 1 thoracoscopic lobectomy from May 2017 to December 2023 were retrospectively analyzed. The median age was 7 months, and the median weight was 8 kg. Included: 4 cases of upper lobectomy, 3 cases of middle lobectomy, and 28 cases of lower lobectomy. <b><i>Results:</i></b> SP + 1 thoracoscopic lobectomy was successfully completed in all infants. One case developed a postoperative air leak. There were no deaths and no other postoperative complications such as pulmonary infection, bleeding, atelectasis, bronchopleural fistula, and chylothorax. <b><i>Conclusion:</i></b> SP + 1 thoracoscopic lobectomy for infants with CPAM is safe, feasible, and cosmetic with satisfactory perioperative results in our preliminary experience.